Crossmark

Neuritis óptica bilateral secundaria a pembrolizumab. Un evento adverso infrecuente secundario a la administración de inhibidores del check-point: a propósito de un caso

Crossref DOI link: https://doi.org/10.1016/j.oftal.2026.502503

Published Print: 2026-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Espacio Santos, P.M.

Rabadán Márquez, F. https://orcid.org/0009-0007-2738-8868
Tejada Calvo, P.

Venegas Cruz, J.

Rodríguez García, J.M.

Bayon Porras, R.M.
License Information

Text and Data Mining valid from 2026-07-01

Text and Data Mining valid from 2026-07-01
More Information

This article is maintained by: Elsevier

Article Title: Neuritis óptica bilateral secundaria a pembrolizumab. Un evento adverso infrecuente secundario a la administración de inhibidores del check-point: a propósito de un caso

Journal Title: Archivos de la Sociedad Española de Oftalmología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.oftal.2026.502503

Content Type: simple-article

Copyright: © 2026 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Document is current

Any future updates will be listed below